Evidence map›Paper›PMID 29471127›Full record

ArticleBiomaterials2018

Targeting CD14 on blood derived cells improves intracortical microelectrode performance.

Hillary W Bedell, John K Hermann, Madhumitha Ravikumar, Shushen Lin, Ashley Rein, Xujia Li, Emily Molinich, Patrick D Smith, Stephen M Selkirk, Robert H Miller and 3 more

Abstract read
In one paragraph

Article in Biomaterials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Irreversible, Self-Aligned Microfluidic Packaging for Chronic Implant Applications.Journal of micromechanics and microengineering : structures, devices, and systems · 2021
    Article
  18. Review
  19. Inhibition of NaJournal of neural engineering · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Hillary W BedellDepartment of Biomedical Engineering, Case Western Reserve University, School of Engineering, 2071 MLK Jr. Drive, Wickenden Bldg, Cleveland, OH 44106, USA; Advanced Platform Technology Center, L. Stokes Cleveland VA Medical Center, Rehab. R&D, 10701 East Blvd. Mail Stop 151 AW/APT, Cleveland, OH 44106, USA.
John K HermannDepartment of Biomedical Engineering, Case Western Reserve University, School of Engineering, 2071 MLK Jr. Drive, Wickenden Bldg, Cleveland, OH 44106, USA; Advanced Platform Technology Center, L. Stokes Cleveland VA Medical Center, Rehab. R&D, 10701 East Blvd. Mail Stop 151 AW/APT, Cleveland, OH 44106, USA.
Madhumitha RavikumarDepartment of Biomedical Engineering, Case Western Reserve University, School of Engineering, 2071 MLK Jr. Drive, Wickenden Bldg, Cleveland, OH 44106, USA; Advanced Platform Technology Center, L. Stokes Cleveland VA Medical Center, Rehab. R&D, 10701 East Blvd. Mail Stop 151 AW/APT, Cleveland, OH 44106, USA.
Shushen LinDepartment of Biomedical Engineering, Case Western Reserve University, School of Engineering, 2071 MLK Jr. Drive, Wickenden Bldg, Cleveland, OH 44106, USA.
Ashley ReinDepartment of Biomedical Engineering, Case Western Reserve University, School of Engineering, 2071 MLK Jr. Drive, Wickenden Bldg, Cleveland, OH 44106, USA.
Xujia LiDepartment of Biomedical Engineering, Case Western Reserve University, School of Engineering, 2071 MLK Jr. Drive, Wickenden Bldg, Cleveland, OH 44106, USA.
Emily MolinichDepartment of Biomedical Engineering, Case Western Reserve University, School of Engineering, 2071 MLK Jr. Drive, Wickenden Bldg, Cleveland, OH 44106, USA.
Patrick D SmithDepartment of Biomedical Engineering, Case Western Reserve University, School of Engineering, 2071 MLK Jr. Drive, Wickenden Bldg, Cleveland, OH 44106, USA.
Stephen M SelkirkAdvanced Platform Technology Center, L. Stokes Cleveland VA Medical Center, Rehab. R&D, 10701 East Blvd. Mail Stop 151 AW/APT, Cleveland, OH 44106, USA.
Robert H MillerNeurosciences, The George Washington University, The School of Medicine & Health Sciences, 2300 Eye Street, NW, Ross Hall, Washington DC 20037, USA.
Steven SidikDepartment of Mathematics, Applied Mathematics and Statistics, Case Western Reserve University, 2049 Martin Luther King Jr. Drive, Yost Hall, Cleveland, OH 44106, USA.
Dawn M TaylorDepartment of Biomedical Engineering, Case Western Reserve University, School of Engineering, 2071 MLK Jr. Drive, Wickenden Bldg, Cleveland, OH 44106, USA; Department of Neurosciences, Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Jeffrey R CapadonaDepartment of Biomedical Engineering, Case Western Reserve University, School of Engineering, 2071 MLK Jr. Drive, Wickenden Bldg, Cleveland, OH 44106, USA; Advanced Platform Technology Center, L. Stokes Cleveland VA Medical Center, Rehab. R&D, 10701 East Blvd. Mail Stop 151 AW/APT, Cleveland, OH 44106, USA. Electronic address: jrc35@case.edu.
Case Western Reserve University · USUniversity School · USLouis Stokes Cleveland VA Medical Center · USGeorge Washington University · US

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARK R CHANCE · 1987 to 2026
$142.3M
Integrated Neural Engineering and Rehabilitation Training ProgramT32EB004314 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI Jeffrey R Capadona, Robert F. Kirsch · 2004 to 2026
$6.1M
CD14 facilitates neural device integration and performanceR01NS082404 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI CAPADONA, JEFFREY R · 2013 to 2016
$1.8M
Resveratrol Prevents Microelectrode Mediated NeurodegenerationI01RX001495 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI CAPADONA, JEFFREY R · 2015 to 2017
–
NCI NIH HHS P30 CA043703NIBIB NIH HHS T32 EB004314NINDS NIH HHS R01 NS082404RRD VA I01 RX001495
6 · The paper itself

Abstract

Intracortical microelectrodes afford researchers an effective tool to precisely monitor neural spiking activity. Additionally, intracortical microelectrodes have the ability to return function to individuals with paralysis as part of a brain computer interface. Unfortunately, the neural signals recorded by these electrodes degrade over time. Many strategies which target the biological and/or materials mediating failure modes of this decline of function are currently under investigation. The goal of this study is to identify a precise cellular target for future intervention to sustain chronic intracortical microelectrode performance. Previous work from our lab has indicated that the Cluster of Differentiation 14/Toll-like receptor pathway (CD14/TLR) is a viable target to improve chronic laminar, silicon intracortical microelectrode recordings. Here, we use a mouse bone marrow chimera model to selectively knockout CD14, an innate immune receptor, from either brain resident microglia or blood-derived macrophages, in order to understand the most effective targets for future therapeutic options. Using single-unit recordings we demonstrate that inhibiting CD14 from the blood-derived macrophages improves recording quality over the 16 week long study. We conclude that targeting CD14 in blood-derived cells should be part of the strategy to improve the performance of intracortical microelectrodes, and that the daunting task of delivering therapeutics across the blood-brain barrier may not be needed to increase intracortical microelectrode performance.

Indexed as

Electrodes, ImplantedMicroelectrodesAnimalsBlood CellsBrainBrain-Computer InterfacesChimeraElectric ImpedanceFemaleHumansLipopolysaccharide ReceptorsMacrophagesMaleMice, Inbred C57BLMicrogliaNeuronsLipopolysaccharide ReceptorsSiliconCD14ElectrophysiologyGliosisInnate immunityIntracortical microelectrodesNeuroinflammation

Identifiers

PMID29471127
PMCPMC5841759
OpenAlexW2789493185

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.